Cobbold JFL - Search Results

1

PYY plays a key role in the resolution of diabetes following bariatric surgery in humans.

Guida C, Stephen SD, Watson M, Dempster N, Larraufie P, Marjot T, Cargill T, Rickers L, Pavlides M, Tomlinson J, Cobbold JFL, Zhao CM, Chen D, Gribble F, Reimann F, Gillies R, Sgromo B, Rorsman P, Ryan JD, Ramracheya RD. Guida C, et al. Among authors: cobbold jfl. EBioMedicine. 2019 Feb;40:67-76. doi: 10.1016/j.ebiom.2018.12.040. Epub 2019 Jan 11. EBioMedicine. 2019. PMID: 30639417 Free PMC article.

2

Non-alcoholic fatty liver disease and diabetes.

Hazlehurst JM, Woods C, Marjot T, Cobbold JF, Tomlinson JW. Hazlehurst JM, et al. Metabolism. 2016 Aug;65(8):1096-108. doi: 10.1016/j.metabol.2016.01.001. Epub 2016 Jan 11. Metabolism. 2016. PMID: 26856933 Free PMC article. Review.

3

Does the death knell toll for phlebotomy in NAFLD?

Ryan JD, Marjot T, Cobbold JF. Ryan JD, et al. Hepatology. 2015 Dec;62(6):1920-1. doi: 10.1002/hep.28029. Epub 2015 Oct 23. Hepatology. 2015. PMID: 26238083 No abstract available.

4

Nonalcoholic Fatty Liver Disease in Adults: Current Concepts in Etiology, Outcomes, and Management.

Marjot T, Moolla A, Cobbold JF, Hodson L, Tomlinson JW. Marjot T, et al. Endocr Rev. 2020 Jan 1;41(1):bnz009. doi: 10.1210/endrev/bnz009. Endocr Rev. 2020. PMID: 31629366 Review.

5

A multidisciplinary approach to the management of NAFLD is associated with improvement in markers of liver and cardio-metabolic health.

Moolla A, Motohashi K, Marjot T, Shard A, Ainsworth M, Gray A, Holman R, Pavlides M, Ryan JD, Tomlinson JW, Cobbold JF. Moolla A, et al. Frontline Gastroenterol. 2019 Oct;10(4):337-346. doi: 10.1136/flgastro-2018-101155. Epub 2019 Apr 30. Frontline Gastroenterol. 2019. PMID: 31682643 Free PMC article.

6

Fighting liver fat.

Koeckerling D, Tomlinson JW, Cobbold JF. Koeckerling D, et al. Endocr Connect. 2020 Jul;9(7):R173-R186. doi: 10.1530/EC-20-0174. Endocr Connect. 2020. PMID: 32621584 Free PMC article. Review.

7

Sodium-glucose cotransporter 2 inhibition does not reduce hepatic steatosis in overweight, insulin-resistant patients without type 2 diabetes.

Marjot T, Green CJ, Charlton CA, Cornfield T, Hazlehurst J, Moolla A, White S, Francis J, Neubauer S, Cobbold JF, Hodson L, Tomlinson JW. Marjot T, et al. JGH Open. 2019 Nov 5;4(3):433-440. doi: 10.1002/jgh3.12274. eCollection 2020 Jun. JGH Open. 2019. PMID: 32514450 Free PMC article.

8

Prevalence and severity of non-alcoholic fatty liver disease are underestimated in clinical practice: impact of a dedicated screening approach at a large university teaching hospital.

Marjot T, Sbardella E, Moolla A, Hazlehurst JM, Tan GD, Ainsworth M, Cobbold JFL, Tomlinson JW. Marjot T, et al. Among authors: cobbold jfl. Diabet Med. 2018 Jan;35(1):89-98. doi: 10.1111/dme.13540. Diabet Med. 2018. PMID: 29094442

9

Hepatic iron is the major determinant of serum ferritin in NAFLD patients.

Ryan JD, Armitage AE, Cobbold JF, Banerjee R, Borsani O, Dongiovanni P, Neubauer S, Morovat R, Wang LM, Pasricha SR, Fargion S, Collier J, Barnes E, Drakesmith H, Valenti L, Pavlides M. Ryan JD, et al. Liver Int. 2018 Jan;38(1):164-173. doi: 10.1111/liv.13513. Epub 2017 Jul 29. Liver Int. 2018. PMID: 28679028

10

Association of Weight Changes With Changes in Histological Features and Blood Markers in Nonalcoholic Steatohepatitis.

Koutoukidis DA, Jebb SA, Tomlinson JW, Cobbold JF, Aveyard P. Koutoukidis DA, et al. Clin Gastroenterol Hepatol. 2022 Mar;20(3):e538-e547. doi: 10.1016/j.cgh.2021.03.047. Epub 2021 Apr 2. Clin Gastroenterol Hepatol. 2022. PMID: 33813074

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

58 results

Search Page

Filters